There are 2949 resources available
76P - The distribution of tumor mutational burden in IDH-mutant solid tumors
Presenter: you lu
Session: E-Poster Display
Resources:
Abstract
77P - Clinical characteristics and therapeutic implications of PALB2 variants in patients with advanced solid tumors
Presenter: Jinesh Gheeya
Session: E-Poster Display
Resources:
Abstract
78TiP - KEYNOTE-966 trial in progress: Pembrolizumab plus gemcitabine and cisplatin for advanced biliary tract cancer
Presenter: Juan Valle
Session: E-Poster Display
Resources:
Abstract
79TiP - A phase II/III, randomized, placebo-controlled study of bintrafusp alfa with gemcitabine plus cisplatin as first-line treatment of biliary tract cancer
Presenter: Do-Youn Oh
Session: E-Poster Display
Resources:
Abstract
80TiP - Global phase III study of NUC-1031 plus cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
Presenter: Jennifer Knox
Session: E-Poster Display
Resources:
Abstract
81TiP - Changes in immune function and prognosis in advanced perihilar cholangiocarcinoma patients treated with immunotherapy combined with different topical therapies
Presenter: Chao Zhao
Session: E-Poster Display
Resources:
Abstract
89P - Machine learning models predict selinexor tolerability and efficacy
Presenter: Yuval Artstein
Session: E-Poster Display
Resources:
Abstract
90P - Abnormal breast detection by an improved AlexNet model
Presenter: Yudong Zhang
Session: E-Poster Display
Resources:
Abstract
91P - Transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer
Presenter: Mariona Baliu Piqué
Session: E-Poster Display
Resources:
Abstract
92P - The prognosis and predictive value of the negative estrogen/positive progesterone breast cancer profile (ER- / PR +): Moroccan experience
Presenter: Sanaa Gamrani
Session: E-Poster Display
Resources:
Abstract